PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma

Pharmaceutical, biotech and other research sponsors can now connect their clinical studies to longitudinal real-world data – speeding up drug development and aligning with the 21st Century Cures Act.

RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma®, PRA’s proprietary technology that allows for the generation of enhanced evidence for drug development. PRA’s solution makes it possible to connect clinical trial data and secondary data sets with privacy at the forefront. Today, three large pharmaceutical companies, along with several other pharmaceutical and biotech companies of all sizes, are using Synoma to link data and conduct analyses across their drug development portfolios.

“Data of all types is widely available from dozens of sources. The missing link, however, is the ability to connect clinical trial data to the insights from real-world data – enabling researchers to understand what is happening outside and after a study in a way that protects privacy,” said Kent Thoelke, Executive Vice President and Chief Scientific Officer, PRA Health Sciences. “Tokenization and linking is the approach researchers can use to glean the greatest insights into drug safety and effectiveness over time.”

PRA can partner with a variety of tokens to multiple sources of information – making it possible to incorporate broader sets of real-world data and revolutionize evidence generation and insights as envisioned by the 21st Century Cures Act.

“Tokenization of siloed patient data sets will be a game-changer for clinical researchers and drug developers,” said Jane Quigley, Senior Vice President, Digital Health, PRA Health Sciences. “Through our acquisition of Symphony Health and partnership with other data sources, we have enabled scientists and research teams to more intelligently evaluate a wider set of data to inform clinical trial protocols, leverage real-world data as eSource, conduct advanced feasibility, speed enrollment and, ultimately, bring novel and differentiated therapies to market faster.”

Contact us to learn more about how Synoma can be applied to clinical studies.

About PRA Health Sciences

PRA Health Sciences is one of the world’s leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA’s global clinical development platform includes more than 75 offices across North America, Europe, Asia, Latin America, Africa, Australia and the Middle East and more than 19,000 employees worldwide. Since 2000, PRA has participated in approximately 4,000 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 95 drugs. To learn more about PRA, please visit


MEDIA INQUIRIES: Laurie Hurst, Sr. Director, Communications and Public Relations | +1 (919) 786-8435

Previous Article

مؤتمر الذكاء العالمي الخامس: في طليعة الابتكار

Next Article

‫ تجمع تمويلًا بقيمة 130 مليون دولار أمريكي لتوسيع نطاق منصتها الصحية الرقمية من أجل رعاية وأبحاث أفضل Huma

Related Posts

فازت شركة زي تي إي بالحصة الأكبر في العطاء المُقام على القسم 4 الخاص بتوريد أجهزة التوجيه المتطورة المركزية لتشاينا موبيل

شنتشن، الصين، 18 سبتمبر 2021، /بي آر نيوزواير/ — شركة زي تي إي (0763. HK / 000063.SZ)، أعلنت اليوم شركة زي تي إي (إحدى أكبر الشركات الدولية الرئيسية التي تقدم خدمات الاتصالات السلكية واللاسلكية والمؤسسية وحلول إنترنت المحمول التقنية للمستهلكين) أنها قامت بتأمين حصة بنسبة 50٪ في القسم 4 الخاص بتوريد أجهزة التوجيه/ التبديل المتطورة المركزية لتشاينا […]

Shanghai Electric Implements Green Construction Practices to Protect Dubai Natural Environment

SHANGHAI, Dec. 28, 2021 /PRNewswire/ — Shanghai Electric (“Shanghai Electric” or “the Company”) (601727.SS and 02727. HK) plays a key role in helping Belt and Road Initiative (BRI) countries build low-carbon and clean energy infrastructure while implementing green construction practices in its efforts to protect local ecological systems and minimize the impact on animal habitats. Shanghai Electric’s […]

TMA Precision Health and Dante Genomics partner to help children with rare diseases through clinical whole genome sequencing solutions

NEW YORK, Sept. 08, 2022 (GLOBE NEWSWIRE) — Dante Genomics, a global leader in genomics and precision medicine, today announced its partnership with TMA Precision Health, a company on a mission to improve the lives of rare disease patients everywhere, offering clinical whole genome sequencing to rare disease patients as the first step in diagnosing […]

فانتاج ترعى فريق ماكلارين الجديد لسباقات الطرق الوعرة الكهربائية

لندن وسنغافورة ، 16 فبراير 2022 /PRNewswire/ — أعلنت فانتاج الوسيط الدولي متعدد الأصول، عن شراكتها متعددة السنوات مع ماكلارين ريسينج كشريك رسمي لفريق ماكلارين إكستريم إي (MX). يأتي هذا الإعلان قبل انطلاق موسم 2022، مع السباق الأول، سباق ديزرت إكس بريكس في المملكة العربية السعودية، والمقرر إقامته في 19 و20 فبراير.  إكستريم إي هو […]